Aprogen Medicines Inc. (KRX:007460)

Market Cap	222.08B
Revenue (ttm)	150.11B
Net Income (ttm)	-58.08B
Shares Out	291.07M
EPS (ttm)	-225.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,636,180
Average Volume	1,766,598
Open	758.00
Previous Close	763.00
Day's Range	750.00 - 792.00
52-Week Range	658.00 - 1,794.00
Beta	0.86
RSI	56.90
Earnings Date	Mar 20, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1971
• Employees: 245
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.